This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

4SC-202

4SC AG

Drug Names(s): 4SC-202

Description: 4SC-202 is an orally administered, selective histone deacetylase (HDAC) inhibitor which is also characterized by an anti-mitotic mechanism of action.


4SC-202 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug